You just read:

Can-Fite Concludes Successful Clinical Investigator Meeting for its ACRobat Phase III Trial of Piclidenoson in the Treatment of Rheumatoid Arthritis

News provided by

Can-Fite BioPharma Ltd.

Jun 08, 2017, 07:00 ET